Try our beta test site

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
DelMar Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01478178
First received: November 14, 2011
Last updated: January 19, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 10, 2017